Use of Patient and Investigator Global Impression Scales: A Review of Food and Drug Administration–Approved Labeling, 2009 to 2019

Identify disease categories in which single-item global impression (GI) scales were included in product labeling of new drugs approved by the US Food and Drug Administration (FDA) in January 2009-December 2019 and review the characteristics of GIs included in product labeling of new FDA-approved dru...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2021-07, Vol.24 (7), p.1016-1023
Hauptverfasser:	Gnanasakthy, Ari, Barrett, Amy, Norcross, Lindsey, D’Alessio, Denise, Romano, Carla (DeMuro)
Format:	Artikel
Sprache:	eng
Schlagworte:	Central nervous system Clinical assessment Clinical outcomes Clinical research Clinical trials Descriptive labeling Drug Approval drug labeling Drug Labeling - trends FDA approval global assessment global impression Humans Musculoskeletal system Nervous system Patient Reported Outcome Measures patient-reported outcomes Patients Prescription drugs Rule of origin United States Wording
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!